National Institute of Neurological Disorders and Stroke; Notice of Meetings, 47504 [06-6962]
Download as PDF
47504
Federal Register / Vol. 71, No. 159 / Thursday, August 17, 2006 / Notices
the statement of the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page:
deainfo.nci.nih.gov/advisory/ncab.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: August 8, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–6964 Filed 8–16–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
rwilkins on PROD1PC63 with NOTICES
National Institute of Neurological
Disorders and Stroke; Notice of
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of meetings of the
National Advisory Neurological
Disorders and Stroke Council.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council,
Council Training Career Development and
Special Programs Subcommittee.
Date: September 13, 2006.
VerDate Aug<31>2005
16:36 Aug 16, 2006
Jkt 208001
Open: 8 p.m. to 10 p.m.
Agenda: To discuss the training programs
of the Institute.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Stephen J. Korn, PhD,
Training and Special Programs Officer,
National Institute of Neurological Disorders
and Stroke, National Institutes of Health,
6001 Executive Blvd., Suite 2154, MSC 9527,
Bethesda, MD 20892–9527, (301) 496–4188.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council,
Council Basic and Preclinical Programs
Subcommittee.
Date: September 14, 2006.
Open: 8 a.m. to 9 a.m.
Agenda: To discuss basic and preclinical
programs policy.
Place: National Institutes of Health,
Building 31, A Wing, 31 Center Drive,
Conference Room 8A–28, Bethesda, MD
20892.
Closed: 9 a.m. to 10 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, A Wing, 31 Center Drive,
Conference Room 8A–28, Bethesda, MD
20892.
Contact Person: Robert Baughman, MD,
Associate Director for Technology
Development, National Institute of
Neurological Disorders and Stroke, National
Institutes of Health, 6001 Executive Blvd.,
Suite 2137, MSC 9527, Bethesda, MD 20892–
9527, (301) 496–1779.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council,
Council Clinical Trials Subcommittee.
Date: September 14, 2006.
Closed: 8 a.m. to 9 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, C Wing, 31 Center Drive,
Conference Room 10, Bethesda, MD 20892.
Open: 9 a.m. to 10 a.m.
Agenda: To discuss clinical trials policy.
Place: National Institutes of Health,
Building 31, C Wing, 31 Center Drive,
Conference Room 10, Bethesda, MD 20892.
Contact Person: John Marler, MD,
Associate Director for Clinical Trials,
National Institute of Neurological Disorders
and Stroke, National Institutes of Health,
6001 Executive Blvd., Suite 2216, Bethesda,
MD 20892, (301) 496–9135, jm137f@nih.gov.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.ninds.nih.gov, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: August 9, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–6962 Filed 8–16–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Child Health and
Human Development; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Advisory Child Health and
Human Development Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Child Health and Human Development
Council.
Date: September 11, 2006.
Open: 8 a.m. to 12:30 p.m.
Agenda: (1) A report by the Director,
NICHD; (2) a report of the Subcommittee on
Planning and Policy; (3) Developmental
Biology, Genetics and Teratology Branch
presentation; and other business of the
Council.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C–Wing,
Conference Room 6, Bethesda, MD 20892.
Closed: 1:30 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C–Wing,
Conference Room 6, Bethesda, MD 20892.
E:\FR\FM\17AUN1.SGM
17AUN1
Agencies
[Federal Register Volume 71, Number 159 (Thursday, August 17, 2006)]
[Notices]
[Page 47504]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-6962]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of meetings of
the National Advisory Neurological Disorders and Stroke Council.
The meetings will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Neurological Disorders and
Stroke Council, Council Training Career Development and Special
Programs Subcommittee.
Date: September 13, 2006.
Open: 8 p.m. to 10 p.m.
Agenda: To discuss the training programs of the Institute.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Stephen J. Korn, PhD, Training and Special
Programs Officer, National Institute of Neurological Disorders and
Stroke, National Institutes of Health, 6001 Executive Blvd., Suite
2154, MSC 9527, Bethesda, MD 20892-9527, (301) 496-4188.
Name of Committee: National Advisory Neurological Disorders and
Stroke Council, Council Basic and Preclinical Programs Subcommittee.
Date: September 14, 2006.
Open: 8 a.m. to 9 a.m.
Agenda: To discuss basic and preclinical programs policy.
Place: National Institutes of Health, Building 31, A Wing, 31
Center Drive, Conference Room 8A-28, Bethesda, MD 20892.
Closed: 9 a.m. to 10 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, A Wing, 31
Center Drive, Conference Room 8A-28, Bethesda, MD 20892.
Contact Person: Robert Baughman, MD, Associate Director for
Technology Development, National Institute of Neurological Disorders
and Stroke, National Institutes of Health, 6001 Executive Blvd.,
Suite 2137, MSC 9527, Bethesda, MD 20892-9527, (301) 496-1779.
Name of Committee: National Advisory Neurological Disorders and
Stroke Council, Council Clinical Trials Subcommittee.
Date: September 14, 2006.
Closed: 8 a.m. to 9 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, C Wing, 31
Center Drive, Conference Room 10, Bethesda, MD 20892.
Open: 9 a.m. to 10 a.m.
Agenda: To discuss clinical trials policy.
Place: National Institutes of Health, Building 31, C Wing, 31
Center Drive, Conference Room 10, Bethesda, MD 20892.
Contact Person: John Marler, MD, Associate Director for Clinical
Trials, National Institute of Neurological Disorders and Stroke,
National Institutes of Health, 6001 Executive Blvd., Suite 2216,
Bethesda, MD 20892, (301) 496-9135, jm137f@nih.gov.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: https://www.ninds.nih.gov, where an agenda and any additional
information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS)
Dated: August 9, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-6962 Filed 8-16-06; 8:45 am]
BILLING CODE 4140-01-M